Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

467 public trials 74 recruiting studies

Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Active, Not Recruiting

A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease

NCT05132166

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

The Skin Microbiome in Graft Versus Host Disease

NCT04231500

Conditions: Graft Versus Host Disease, Graft Versus Host Disease in Skin, Graft vs Host Disease, +2 more
Locations: Department of Dermatology; University Hospital Basel Basel, Switzerland

View Trial Details

Active, Not Recruiting

Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

NCT02105766

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

IRENE-G Study: Impact of Resistance Exercise and Nutritional Endorsement on GvHD Symptoms

NCT05111834

Conditions: Behavior, Graft vs Host Disease, Immune System Diseases, +2 more
Locations: Heidelberg University Hospital Heidelberg, Germany

View Trial Details

Active, Not Recruiting

GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG

NCT05153226

Conditions: AML, CMML, Graft vs Host Disease, +4 more
Locations: Uniklinik RWTH Aachen Aachen, Germany

Univeristätsklinikum Augsburg Augsburg, Germany

Klinikum Chemnitz gGmbH Chemnitz, Germany

Universitätsklinikum Köln Cologne, Germany

View all 23 locations

View Trial Details

Active, Not Recruiting

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis

NCT06475820

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +19 more
Locations: Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, Samory-Mashela,1, Russia

View Trial Details

Active, Not Recruiting

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

NCT01744223

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +16 more
Locations: Emory University Winship Cancer Institute Atlanta, Georgia, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

University Hospitals of Cleveland Cleveland, Ohio, United States

View Trial Details

Graft vs Host Disease

Graft vs Host Disease trial results

A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease

The Skin Microbiome in Graft Versus Host Disease

Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

IRENE-G Study: Impact of Resistance Exercise and Nutritional Endorsement on GvHD Symptoms

GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

Related conditions